Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sandoz concludes acquisition of antifungal agent Mycamine from Astellas

Ruchika Sharma28 Aug 2023 5:40 PM IST

Basel: Sandoz has successfully completed the acquisition of worldwide brand rights for systemic antifungal agent Mycamine (micafungin sodium, Funguard...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark recalls 1200 bottles of generic hypertension drug in US over manufacturing issue

Ruchika Sharma28 Aug 2023 4:33 PM IST

New Jersey: Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due...

Indian pharma sector expected to grow at rapid pace: PM Modi

Ruchika Sharma28 Aug 2023 3:30 PM IST

Citing the example of the pharmaceutical industry, the prime minister said the sector worth Rs four lakh crore at present is expected to grow to Rs 10...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Gland Pharma gets 2 USFDA observations for Pashamylaram Facility

Ruchika Sharma28 Aug 2023 2:30 PM IST

Telangana: Gland Pharma has announced that the Office of Medical Device and Radiological Health Operations (OMDRHO), United States Food and...

CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study

Sun Pharma looking to fully acquire Israel based unit Taro Pharmaceutical Industries: MD Dilip Shanghvi

Ruchika Sharma28 Aug 2023 1:30 PM IST

Sun Pharma currently owns around 78 per cent stake in Taro.

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck, Eisai to shut down late stage study for combo cancer therapy

Ruchika Sharma28 Aug 2023 12:31 PM IST

The companies are testing the combination to treat a range of cancers, including those affecting the lungs and stomach.

GSK, Pfizer resolve patent lawsuit over RSV vaccines

Alnylam plans to appeal ruling on patents related to Moderna COVID vaccine

Ruchika Sharma28 Aug 2023 11:30 AM IST

Bengaluru: Alnylam Pharmaceuticals has said it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents...

Gilead Sciences gets USFDA nod for new Biktarvy indication

USFDA nod to Gilead Sciences Veklury to treat COVID19 in people with mild to severe hepatic impairment with no dose adjustment

Ruchika Sharma27 Aug 2023 2:30 PM IST

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug...

Alert does not reflect current situation: Indian Immunologicals on fake Abhayrab claims

Indian Immunologicals expects to commercially launch dengue fever vaccine by early 2026

Ruchika Sharma27 Aug 2023 12:30 PM IST

IIL's managing director, K Anand Kumar, said the vaccine's early stage trials conducted on about 90 individuals, aged 18-50 years, did not demonstrate...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer gets European Commission marketing nod for RSV vaccine Abrysvo to protect infants, older adults

Ruchika Sharma27 Aug 2023 11:00 AM IST

New York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, the company’s bivalent...

Cigna removes pre authorization requirement for 25 percent of medical services

Ruchika Sharma27 Aug 2023 9:00 AM IST

United States: Health insurer Cigna Group said on Thursday it would remove the use of prior authorization or paperwork required to get approval for...

Zydus Lifesciences to present on ZYIL1 at International Congress of Parkinson's Disease and Movement Disorders

Ruchika Sharma26 Aug 2023 1:30 PM IST

ZYIL1 is a novel oral small molecule NLRP3 inhibitor.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok